pfizer glp-1 news joining race: How Novo & Eli Lilly compare Pfizer's monthly obesity shot has

To interrogate the robustness of the impact of S

Medicaid coverage for weight loss medications, including GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound), varies dramatically from state to state

While the FDA has approved Ozempic as a diabetes drug, the FDA has not approved using it for weight loss

These drugs are becoming more common

The mice were then decapitated and the entire brain was removed and immediately submerged in ice-cold, carbogen-saturated (95% O 2 and 5% CO 2 ) aCSF (126 mM NaCl, 2.8 mM KCl, 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 and 5 mM glucose)